Bioactive compounds from Prosthechea karwinskii decrease obesity, insulin resistance, pro-inflammatory status, and cardiovascular risk in Wistar rats with metabolic syndrome
Publication date: Available online 25 June 2021Source: Journal of EthnopharmacologyAuthor(s): Gabriela Soledad Barragán-Zarate, Alfonso Alexander-Aguilera, Luicita Lagunez-Rivera, Rodolfo Solano, Ida Soto-Rodríguez
Source: Journal of Ethnopharmacology - Category: Drugs & Pharmacology Source Type: research
More News: Cardiology | Cardiovascular | Drugs & Pharmacology | Eating Disorders & Weight Management | Heart | Insulin | Metabolic Syndrome | Obesity